Intrommune Private Investor Briefing - Virtual
by CONNECTpreneur Investor Network
MONDAY, March 23, 11:30 am EDT
Dear Investors,
Opus8 is hosting a virtual, invitation-only private investor briefing featuring Intrommune, a consumer health company pioneering a new approach to peanut allergy prevention.
Intrommune’s patented platform delivers allergens through a familiar daily routine—brushing your teeth. By administering controlled exposure through toothpaste, the technology trains the immune system and aims to prevent life-threatening peanut allergies through a simple, consumer-friendly delivery method.
Company Overview
Intrommune is developing a consumer-grade immunotherapy platform designed to make allergy prevention safe, simple, and scalable. By combining biotech-grade science with a routine daily behavior, the company is creating a new category in preventive allergy care. With early clinical validation and commercial traction already underway, Intrommune is positioned at the intersection of healthcare innovation and consumer accessibility.
What Differentiates Intrommune
• Clinically Validated Approach — In the Phase 1 peanut allergy study, patients achieved 97% adherence with zero dropouts and zero cases of anaphylaxis
• Early Commercial Traction — The company began generating revenue through its distribution channels in November 2025
• Large and Underserved Market — More than 33 million Americans suffer from food allergies, with limited treatment options currently available
• First-Mover Consumer Platform — The only biotech-grade allergy immunotherapy delivered in a consumer-ready toothpaste format
• Experienced Leadership — Led by seasoned executives and advisors from across biotech, healthcare, and consumer health
Event Details:
Date: March 23
Time: 11:30 AM EDT
Location: Online via Zoom
Please note that this meeting is for DIRECT and ACTIVE Accredited investors only. All RSVPs must be pre-registered on this Eventbrite site with the investor criteria filled out. All RSVPs are subject to review and approval. We will provide a confirmation email and a calendar invitation after you register.
Request investor materials by contacting Avery North at anorth@opus8.com
Thanks much and all the best,
Tien Wong
CEO,
Opus8, Inc.